Background: Prospective studies in the general population show that slow gait speed is associated with cognitive decline and clinical progression to dementia. However, longitudinal studies in memory clinic populations are mostly lacking. We aimed to study the association between gait speed and grip strength and cognitive functioning at baseline and cognitive decline over time in memory clinic patients with subjective cognitive decline and mild cognitive impairment. Methods: We included 309 patients (age 70 ± 9 years, 108 [35%] women, Mini-Mental State Examination 27 ± 3 points). Baseline gait speed was assessed over 15 feet, grip strength with a hydraulic hand dynamometer. Cognitive functioning was assessed annually with a comprehensive test battery during 3 years. Results: Age-and gender-adjusted linear mixed models showed that slower gait speed was related to worse baseline attention, memory, information processing speed, and verbal fluency. Longitudinally, gait speed was related to decline in information processing speed and executive functioning. Weaker grip strength was related to worse baseline information processing speed and executive functioning but there were no longitudinal associations. Cox proportional hazards models revealed no significant associations with clinical progression. Conclusions: Our findings suggest that markers of physical performance are related to current cognitive status and modestly related to cognitive decline but are seemingly not useful as an early marker of incident clinical progression.
with MCI have decreased physical functioning compared to healthy peers in the general population (12, 13) . The term subjective cognitive decline (SCD) refers to patients who show a subjective experience of cognitive decline without objective evidence of cognitive decline (14) . Studies on gait speed and grip strength in relation to cognitive functioning in MCI and SCD are scarce. In a study on MCI, crosssectional relationships have been found between slow gait speed and worse performance of memory, information processing speed, and executive functioning, while weak grip strength was related to worse information processing speed (15) . Moreover, a pilot study including 13 patients with MCI found that patients with slower gait speed had a higher risk of progression to Alzheimer's disease in comparison to patients with faster gait speed (16) . Measures of gait speed and grip strength are noninvasive and widely available (1) , making them interesting clinical markers to consider in addition to more established but more invasive markers. Yet, evaluating the potential clinical use of gait speed and grip strength requires longitudinal studies in memory clinic populations. We aimed to study whether baseline gait speed and grip strength are associated with current cognitive functioning and cognitive decline over time in patients who present with SCD or MCI at a memory clinic. In addition, we studied whether gait speed and grip strength were associated with clinical progression to MCI and dementia.
Materials and Methods

Participants
The present study used data from the MCI cohort of the prospective Clinical Course of Cognition and Comorbidity (4C) study (17) . This is a longitudinal multicenter study with 3-year followup aimed at assessing the prognosis of memory clinic visitors with SCD and MCI. Participants were included from the following three university memory clinics: VU University Medical Center, Alzheimer Center in Amsterdam (18) ; Alzheimer Center Limburg at Maastricht University Medical Center in Maastricht; and Radboud Alzheimer Center at Radboud University Medical Center in Nijmegen, The Netherlands. Inclusion criteria were as follows: age of 55 years or older and subjective or objective cognitive impairment but no dementia on baseline neuropsychological assessment. Exclusion criteria were the absence of a primary caregiver, the expectation that the participant would not be able to have at least one follow-up, and the presence of neurological disorders that could have caused cognitive impairment, such as Parkinson's diseases, Huntington's disease, normal pressure hydrocephalus, Korsakoff's syndrome, and a history of brain tumor or encephalitis. For the present study, patients were selected with available scores on measures of gait speed and/or grip strength at baseline, yielding a total sample size of 309 patients. The three sites contributed equally (Amsterdam: n = 98; Maastricht: n = 113; Nijmegen: n = 98). The local ethical committees from the sites approved the study procedures. All patients provided written informed consent.
At first visit, all patients received a standardized 1-day diagnostic work-up, including medical history, informant-based history, physical and neurological examination, assessment of daily functioning, and neuropsychological assessment (for a description of the neuropsychological assessment, see the Neuropsychological Assessment section). During multidisciplinary meetings, diagnoses of MCI (n = 168) were made based on clinical judgment, based on the Petersen criteria (19, 20) . Patients with no objective cognitive impairment and no clinical diagnosis of MCI were classified as having SCD (n = 141). Comorbidities were assessed using the Cumulative Illness Rating Scale for geriatric patients (CIRS-G) (21) . We used an adapted version of the CIRS-G excluding the psychiatric illness category from the total score. By removing this category, the total score reflects a more pure physical comorbidity. The adapted total score ranges from 0 (no problems) to 52 (extremely severe problems).
Following baseline, 46 patients (15%) dropped out of the study. For a description of the patients who dropped out, see the Results section. Annual follow-up assessments took place during 3 years between the years of 2010 and 2014 and consisted of medical, neurological, and neuropsychological examinations. The level of cognitive functioning was assessed according to norms for the Dutch healthy population (see the Neuropsychological Assessment section). Cognitive impairment on a cognitive domain was indicated when the test scores in that domain were on average 1.5 SD below the normative mean, adjusted for age and educational level. Subsequently, diagnoses were re-evaluated in a multidisciplinary team, consisting of at least a neurologist and a neuropsychologist. Diagnoses of dementia were based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) criteria for dementia (22) and subsequently on the clinical National Institute of Aging -Alzheimer's Association (NIA-AA) criteria for Alzheimer's disease (23, 24) and established clinical criteria for other dementia subtypes (25) (26) (27) . In the present study, clinical progression was defined as progression to MCI or dementia for SCD patients and to dementia for MCI patients. In the analyses, the first moment of clinical progression was used, implying that if patients progressed from SCD to MCI and later to dementia, we used the first event of progression.
Assessment of Gait Speed and Grip Strength
Gait speed and grip strength were assessed in accordance with the frailty phenotype of Fried and colleagues (1) . Gait speed was assessed at fast pace over a distance of 15 feet (4.6 m) in seconds. The test was performed indoors on a flat surface. Patients were allowed to use assistive devices when needed. The distance was walked twice and the mean gait speed (m/s) was calculated. Grip strength, in kilogram force (kgf), was assessed using a hydraulic hand dynamometer (Jamar; Lafayette Instruments, Lafayette, IN). Patients were asked to stand or sit with their arm outstretched horizontally away from the body and to squeeze as hard as possible with their dominant hand. The mean grip strength was calculated from two attempts. To allow comparison, scores of gait speed and grip strength were standardized into z-scores using the scores of patients with SCD as reference group.
Neuropsychological Assessment
All centers used the same standardized test battery to assess cognitive functioning annually. To screen global cognitive functioning, we used the Mini-Mental State Examination (MMSE) (28) . For memory, total immediate recall and delayed recall of the Dutch version of the Rey Auditory Verbal Learning Test (RAVLT) (29, 30) and the Visual Association Test (VAT) (31) were used. Attention was assessed using the Digit Span (32) . Information processing speed and executive functioning were assessed with the Letter Digit Substitution Test (LDST) (33) , the Stroop Color Word Test (SCWT) (34, 35) , and the Trail Making Test (TMT) (36, 37) . The average speed on SCWT cards 1 and 2 was used as a measure of information processing speed, as was TMT A and the LDST. A SCWT interference score, calculated as card 3 -([card 1 + card 2]/2) (38), as well as TMT B were used as measures for executive functioning. Verbal fluency was measured using a 1-minute animal fluency test (39) . Missing scores on TMT B were 13% across all follow-ups. We replaced missing TMT B scores by single imputation of the mean B/A-index of that time point multiplied by TMT A, resulting in 4% missing values. On the other tests, 1% to 9% of the scores were missing. These scores were not imputed. All test scores were standardized into z-scores adjusted for age, gender, and education based on the norms for the Dutch healthy population (30) (31) (32) (33) (37) (38) (39) . TMT and SCWT z-scores were inverted (−1 × z-score) to let higher scores reflect better performance.
Statistical Analysis
For statistical analysis, SPSS 20.0 was used (IBM for Windows, NY). Baseline characteristics of patients with a baseline diagnosis of MCI and SCD were compared using Independent samples t test and χ 2 tests when appropriate. Linear mixed models were used to estimate associations between gait speed and grip strength (independent variables in separate models) and cognitive functioning. Three patients without available neuropsychological test scores were excluded for this analysis. Linear mixed model includes observations from all available time points. The neuropsychological z-scores were used as dependent variables (separate models for each test). The model included terms for either grip strength or gait speed, time, and the interaction term of Gait speed or Grip strength × Time. All models were adjusted for age, gender, and center. We assumed a random intercept and a random linear slope for time (in years). The covariance type was set to unstructured. Cox proportional hazard models were used to estimate the risk of clinical progression in relation to baseline gait speed and grip strength. We calculated the hazard ratio (HR) for a unit standard deviation difference in gait speed and grip strength. Gait speed and grip strength were included as independent variables in separate analyses. We used two models: In Model 1, the HR was adjusted for age, gender, education, and center; Model 2 was additionally adjusted for CIRS-G cardiac and vascular sub scores. Finally, we repeated all analyses stratified for baseline diagnosis (SCD/MCI) and for age (≤65/>65 years).
Results
Patient Characteristics
Patients were on average 69.6 ± 8.5 years old, 108 (35%) were women, and the mean baseline MMSE was 27 ± 2.5 points. One hundred and ninety-six (63.4%) patients had no cardiac problems, 62 (20.1%) patients had mild-to-moderate cardiac problems, and 51 (16.5%) patients had severe cardiac problems. One hundred and twenty (38.8%) patients had no vascular problems, 146 (47.3%) patients had mild-to-moderate vascular problems, and 43 (13.9%) patients had severe vascular problems. Table 1 shows the patient characteristics according to baseline diagnosis. Mean gait speed was slower in MCI than in SCD patients (1.2 ± 0.4 and 1.4 ± 0.6 m/s, p = .006). There was no difference in mean grip strength between groups.
Characteristics of Drop Outs
Forty-six patients (15%) dropped out of the study following baseline. The main reasons for drop out were refusing to participate in follow-ups (27 [59%] ) and mortality (9 [20%] ). Patients who dropped out were older (74.6 ± 9.1 and 68.8 ± 8.1 years, p < .001), scored lower on the MMSE (26.1 ± 3.0 and 27.1 ± 2.4, p = .03), had more comorbidities (CIRS-G total score: 9.5 ± 5.3 and 6.5 ± 4.4, p = .001), had slower gait speed (1.1 ± 0.4 and 1.3 ± 0.5 m/s, p < .001), and weaker grip strength (28.7 ± 10.5 and 33.3 ± 11.9 kgf, p = .01) at baseline than patients who did participate in follow-ups.
Associations With Cognitive Functioning
Age-, gender-, and center-adjusted linear mixed models with random intercept and random slope were used to assess the association between baseline gait speed and grip strength and cognitive functioning. We found associations between slower gait speed and worse baseline performance on measures of memory, attention, information processing speed, and verbal fluency (Table 2) . Furthermore, slower baseline gait speed was related to a faster rate of decline on SCWT card III, a measure of information processing speed and executive functioning (β ± SE = .13 ± 0.07, p = .046). In contrast, for digit span total, a measure of attention, we found that slower baseline gait speed was associated with improvement over time (β ± SE = −.07 ± 0.03, p = .006). There were no other associations between baseline gait speed and cognitive decline over time. Weaker grip strength was associated with worse baseline performance on measures of information processing speed and executive functioning. There were no associations between baseline grip strength and cognitive decline over time. When we stratified the analyses for baseline diagnosis (SCD/MCI) and age group (≤65/>65 years), we found that associations were largely attributable to patients with a baseline diagnosis of MCI and with a higher age (Tables 3 and 4) .
Associations With Clinical Progression
During a mean follow-up of 2.1 ± 1.2 years, 88 patients showed clinical progression. Of the patients with a baseline diagnosis of SCD, 23 (16%) converted to MCI and 14 (10%) to dementia. Of the patients with MCI on baseline, 51 (30%) converted to dementia. Cox proportional hazards models showed no associations between baseline gait speed and grip strength and clinical progression to MCI or dementia. When we stratified the analyses for baseline diagnosis (SCD/MCI), we found a borderline-significant relationship between gait speed and clinical progression in patients with MCI (HR = 1.62, 95% CI: 0.93-2.81, p = .09), while there was no such relationship in SCD (HR = 0.97, 95% CI: 0.64-1.45, p = .86). Stratified for age (≤65/>65 years) we found that slower gait speed was associated with an increased risk of clinical progression in the older age group (HR = 1.49, 95% CI: 1.00-2.23, p = .05) but not in the younger age group (HR = 0.81, 95% CI: 0.46-1.44, p = .47). After additional adjustment for the CIRS-G cardiac and vascular subscores, the results remained essentially unchanged (Table 5) .
Discussion
In a memory clinic population of patients with SCD and MCI, we confirmed cross-sectional associations between slower gait speed and weaker grip strength and worse baseline cognitive performance on measures of memory, attention, information processing speed, verbal fluency, and executive functioning. Longitudinally, we found associations between slower baseline gait speed and decline on SCWT card III, a measure of information processing speed and executive functioning, as well as progression to dementia, in patients with MCI and age 65 and older. Weaker grip strength was neither associated with cognitive decline over time nor with clinical progression. This is the first longitudinal study investigating gait speed and grip strength in relation to cognitive functioning in a large, multicenter memory clinic population of patients with SCD and MCI. a CIRS-G total score is an adapted score, excluding the psychiatric category (range: 0-52 points). 
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.02 (0. Strengths of this study are that we used an extensive neuropsychological protocol to assess cognitive functioning, which was standardized across sites. In previous studies, cognitive functioning was often assessed with a single measure (2) (3) (4) . With the comprehensive neuropsychological protocol, we were able to study the relationship between gait speed and grip strength and cognitive functioning in different domains, and hence, to give a more detailed picture than using a single measure. Although we found cross-sectional associations with cognitive functioning associated with a number of cognitive tests, largely assumed to depend on intact frontal brain function, we found one association with a memory task. It is conceivable that motor functions are more strongly associated with cognitive functions with a presumed frontal brain substrate.
The longitudinal associations in this study were modest. We found an association between slow baseline gait speed and decline in information processing speed and executive functioning in the total group. Counter intuitively, we found an inverse association for attention; patients with slower baseline gait speed showed improvement over time. We are not sure how to interpret this finding. For grip strength, we did not find any associations with cognitive decline. Likewise, when we evaluated clinical progression to MCI or dementia as an outcome measure, we found no associations.
Cross-sectional associations between both gait speed and grip strength and cognitive functioning were stronger in patients with MCI than in patients with SCD, in particular for the speed-executive functioning domain. Although less clear, this trend was also visible for the longitudinal associations concerning gait speed, not grip strength, and cognitive decline and clinical progression. This suggests that slow gait speed may not be an early marker for cognitive decline and increased risk of progression but that associations might be stronger in more advanced stages.
Our findings in a memory clinic cohort are in contrast when compared to prospective cohort studies in the general population, who have found convincing associations between gait speed and cognitive decline (5) and an increased risk of incident dementia (11) . The general population cohorts are in general much larger than memory clinic cohorts and the modesty of the longitudinal associations we have found may therefore be due to a power problem. However, when comparing effect sizes, except for the information processing speed and executive domains, effect sizes are smaller in our study than in some prospective cohort studies in the general population (5) . This suggests that the differences are due to more than a mere power difference. Memory clinic and general population cohorts differ in essence. Memory clinic patients with SCD and MCI are at increased risk for dementia compared to the general population; it might be that for these groups, other predictors are more important in relation to clinical progression. Also, on average, most population cohorts are older than our sample. In a recent study, it was found that the relationship between slow gait speed and weak grip strength and cognitive decline is age-specific, with a trend toward a stronger relationship in older age groups (40) . This is also supported by our finding that most associations were largely attributable to a higher age. Furthermore, our sample suffered less from cardiovascular problems than the general population cohorts. Recently, it has been suggested that the association between gait speed and cognitive decline might be stronger in patients suffering from cardiovascular diseases (41) .
Several other explanations also come to mind concerning the modest longitudinal associations that we found. First, in our study, we had some drop outs. The drop outs were older, had more comorbidities, and had slower gait speed and weaker grip strength at baseline than patients who completed follow-ups. If patients dropped out due to steeper cognitive decline, these drop outs may in fact have diluted the effect of gait speed and grip strength. Our use of linear mixed model is important in this respect, as it can handle missing data by taking into account all available follow-ups. However, the results of the Cox regression have to be interpreted with caution, because selective drop outs may have caused bias. Second, it could be that in our young population, simple gait speed and grip strength may not be the most optimal measures. In younger people, physical impairments may be subtler than in older people. More complex or challenging tasks may be better able to detect these subtle disturbances. For gait speed, one option is to use dual tasks. Dual gait tasks have been found to have an executive element, which has not been found in simple gait speed tasks (42) . Indeed, the Walking Trail Making Test has been found to be informative in the absence of obvious physical impairment (43) . It may be explored in the future whether more complex tasks are able to detect longitudinal associations in a relatively young memory clinic population. Fourth, the subtype of MCI, that is amnestic MCI versus nonamnestic MCI, might have influenced our results. Previous findings have shown that patients with amnestic MCI more often have neurological gait dysfunction than patients with nonamnestic MCI Notes: HR = hazard ratio; MCI = mild cognitive impairment; SCD = subjective cognitive decline. Gait speed and grip strength were standardized with the SCD patients as reference group. Cox proportional hazard models. Analyses were stratified for baseline diagnosis (SCD/MCI) and for age (≤ 65/> 65 y).
a Model 1: HR adjusted for age, gender, education, and center. (12). Finally, reverse causality needs to be considered. We hypothesized that impairments in physical functioning precede cognitive decline (2-5) but the reverse has also been shown (44) (45) (46) . When the bidirectional association is studied directly, declining gait speed seems to be a stronger predictor for cognitive decline than vice versa (47) . Finally, it has been suggested that the simultaneous presence of physical and cognitive impairments predicts a higher risk of dementia compared to people without this combination of impairments (7, 9, 41) .
To conclude, in a memory clinic population of patients with SCD and MCI, we found baseline associations between slow gait speed and weak grip strength and worse performance on measures of attention, memory, information processing speed, executive functioning, and verbal fluency. Longitudinally, we found that slower baseline gait speed was related to cognitive decline in some domains, however grip strength was neither related to cognitive decline nor did we find associations with clinical progression. All in all, longitudinal associations were modest and largely attributable to a baseline diagnosis of MCI and higher age. This suggests that slow gait speed may not be an early marker for cognitive decline and increased risk of progression but that associations might be stronger in more advanced stages.
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